Mission Genomics to launch the UK economy

UK-wide genetic testing will boost health, save lives, and create a new pathway for economic innovation, says Dr Stuart J. Grice, co-founder and CSO at FitnessGenes. The United Kingdom is at the forefront of genomics...

Collaboration, Clustering and Converting

Partnerships between small biotechs and Big Pharma could unlock faster drug development for rare diseases, says Dan Williams, PhD, CEO of SynaptixBio. In an increasingly interconnected and competitive world, collaboration has become an essential tool...

Life Science success

Whilst the recent past has been one of huge uncertainty with regards to the political and economic landscape across the globe, the past year saw major success in Life Sciences & Healthcare across the...

T cells: their increasing significance in infectious disease diagnosis and research

Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses...

Uncovering new cures from cancer survivors

Researchers at Oxford techbio Etcembly hope to find new targets for cancer therapies by analysing the immune cells of cancer survivors, as principal scientist Mathew Jones explains. Despite all the advances in medicine over the...

Raising awareness of PSP and CBD

Ellen Rossiter speaks to Andrew Symons,  Chief Executive of PSP Association, about the work of the association and his hopes for the future. Imagine striving daily to raise awareness of, and to find a cure...

Why life science incubators are crucial

In this issue of BioScience Today, we speak to Dr Glenn Crocker MBE, Chief Executive Officer of BioCity – the largest life science incubator business in the UK. The lowdown on life science incubators “A life...

Biosample provenance: what researchers need to know

Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates. The journey for every biospecimen used for...

PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL

A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths. In this, the final feature in a three-part...

Biotech pioneer tackles the biology of ageing

Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen...

Making clinical trials right for older people

In this issue, we speak to Miles Witham, Professor of Trials for Older People at Newcastle University and consultant geriatrician, about why he’s bringing about a sea change in how clinical trials involving older...

SAGES TEACH THE ART OF ADAPTING TO CLIMATE CHANGE

While the conversation about climate change has been dominated by mitigation, what is equally crucial is the need to adapt to the unavoidable changes already on their way. “We have absolutely no choice but...

Llamas: leading the pack in new cancer therapy

Llama antibodies - known as VHHs or nanobodies - could be a gamechanger for precision medicine. Marion Cubitt, Director of Discovery at Isogenica, explains how an accidental discovery opened a fresh pathway for immunotherapy. Tell...

Meeting contemporary medical challenges

In this issue of BioScience Today, we speak to Professor Phil Blower, Chair in Imaging Chemistry at King’s College London about why a multidisciplinary approach is crucial to meeting the medical challenges of today. “I...

THE ROAD LESS TRAVELLED

A Women in Science event that took place in Newcastle upon Tyne’s Biosphere business incubator earlier this year certainly demonstrated that women are finally coming into their own in the fields of science, technology,...

The changing face of cancer care

Breast cancer patients could be spared unnecessary chemotherapy thanks to a new gene test. Karen Southern chats to surgical oncologist, Prof Simon Holt, about how genomic breakthroughs like Oncotype DX are transforming UK cancer...